×

Business / Stock Market

KemPharm Announces Amendment to Licensing Agreement with Gurnet Point Capital Affiliate Following FDA Approval of AZSTARYS™

Published Apr 08 2021 at 8:05 PM GMT

Business Insider

Business Insider @businessinsider.com

Add to Collections
Report Post

Continue reading at businessinsider.com

Key
Points

Amendment Increases Total Potential Regulatory and Sales Milestone Payments to $590 Million, and Adds a New Top-Level Tier for Royalties on US Net SalesConference Call and Live Audio Webcast.

Credit

Tags

Continue reading at businessinsider.com

Posted in Business, Stock Market

Stats

Published Apr 8, 2021 8:05 PM GMT